The AMAZE Program will encompass two double-blind phase 3 trials investigating Quilience versus placebo in adult patients with narcolepsy, commencing this summer at multiple US sites.
Read More
Inspire Medical Systems Inc, a medical technology company focused on the development of solutions...
Read More
The approval was supported by phase 3 results that demonstrated Quviviq improved sleep onset, sleep maintenance, and self-reported total sleep time in adults with insomnia.
Read More
A new study reveals that the effects of the spring and fall time changes on sleep health are not equal, as one leads to short-term sleep disturbances while the other has no significant impact.
Read More
Researchers found that spindle rate frequency increased following exposure to stressful images, providing compelling evidence that stress was a contributing factor in spindle-specific sleep rhythm changes.
Read More